Who May Benefit from TMS Therapy? Eligibility Considerations for Patients with Treatment-Resistant Depression
For individuals living with depression that has not responded to standard treatments, Transcranial Magnetic Stimulation (TMS) may represent a meaningful alternative. If you or a loved one is considering this option, understanding the eligibility criteria is an essential first step. Along with clinical questions, many patients also want to know how much does TMS therapy cost-and the answer is often closely tied to whether they meet specific eligibility requirements. At TMS Revitalizes in Missoula, MT, the clinical team works with patients to evaluate both medical candidacy and the practical aspects of pursuing treatment.
What Is TMS and How Does It Address Treatment-Resistant Depression?
TMS is a non-invasive, FDA-cleared treatment that uses focused magnetic pulses to stimulate specific regions of the brain involved in mood regulation. Unlike systemic medications that circulate throughout the body, TMS directly targets neural circuits associated with depression. The procedure does not require anesthesia, sedation, or recovery time, and patients are typically able to return to their normal activities immediately after each session.
TMS has been FDA-cleared for the treatment of major depressive disorder (MDD) since 2008, and its clinical evidence base has continued to expand through 2026. Research suggests that approximately 50–60% of individuals with treatment-resistant depression may experience meaningful symptom reduction with TMS, and a notable percentage may achieve remission. These outcomes have contributed to TMS becoming an increasingly established option in depression care-particularly for patients who have not found adequate relief through medication alone.
In Missoula, TMS Revitalizes provides TMS therapy specifically for patients with treatment-resistant depression, offering a specialized clinical setting dedicated to this advanced approach.
Clinical Eligibility Criteria for TMS Therapy
Not every person with depression will be a candidate for TMS. Eligibility is determined through a thorough clinical evaluation that examines several key factors. Understanding these criteria can help prospective patients assess whether pursuing a consultation may be a productive next step.
A Diagnosis of Treatment-Resistant Depression
The primary indication for TMS is treatment-resistant depression (TRD), which refers to major depressive disorder that has not adequately responded to prior treatment efforts. Studies indicate that roughly 30–33% of patients with MDD are resistant to medication, and more than half may fail to respond to first-line antidepressant therapy. For these individuals, TMS offers an evidence-based, non-pharmacological option that works through an entirely different mechanism than traditional medications.
It is important to understand that treatment-resistant depression does not mean depression is untreatable. Rather, it means the approaches tried so far have not produced sufficient results, and alternatives like TMS may be worth exploring.
Prior Medication and Therapy History
A detailed review of a patient’s treatment history is central to the eligibility evaluation. Clinicians will typically assess:
- The types and classes of antidepressant medications previously prescribed
- The dosages used and the duration of each medication trial
- Whether evidence-based psychotherapy, such as cognitive behavioral therapy, has been attempted
- The patient’s response to each treatment, including any partial improvements or intolerable side effects
In general, many clinical guidelines reference a history of at least two to four adequate antidepressant trials as a benchmark for establishing treatment resistance. This documentation is a key component of determining whether a patient meets the eligibility threshold for TMS.
Medical and Safety Considerations
Because TMS involves magnetic pulses, certain medical conditions and implanted devices may affect a patient’s candidacy. Individuals with metallic implants in or near the head-such as cochlear implants, aneurysm clips, or metallic plates-may not be suitable candidates, as the magnetic field could interact with these devices. Patients with a history of seizures or epilepsy may also require additional evaluation, though the seizure risk associated with TMS is considered very low in clinical settings.
During an eligibility assessment at TMS Revitalizes, the clinical team carefully reviews each patient’s complete medical history to identify any potential contraindications and ensure treatment can be administered safely.
How Eligibility May Influence the Cost of TMS Therapy
How much does TMS therapy cost? This is one of the most common questions prospective patients ask, and the answer often depends significantly on eligibility factors and individual clinical circumstances.
TMS therapy for treatment-resistant depression is covered by many major insurance plans. At TMS Revitalizes, accepted insurance providers include Aetna, BCBS, Cigna, Medicaid, Optum, Tri-Care, and United Healthcare. Patients are encouraged to contact TMS Revitalizes directly to discuss their individual situation and learn more about what may be available to them.
Because eligibility is a central part of determining whether TMS is the right treatment path, the clinical evaluation helps ensure that TMS is medically appropriate for a given patient. Patients who have questions about how much TMS therapy costs in their specific situation are encouraged to reach out to TMS Revitalizes for personalized guidance.
Who May Not Be an Ideal Candidate for TMS?
While TMS may be appropriate for many individuals with treatment-resistant depression, there are situations in which it may not be recommended. Recognizing these scenarios can help set realistic expectations and guide patients toward the most suitable treatment path.
- Patients without adequate prior treatment trials: If a patient has not yet attempted standard antidepressant medications or psychotherapy at sufficient doses and duration, clinicians may recommend exploring those options before considering TMS.
- Individuals with certain metallic implants near the head: As discussed, the magnetic fields used during TMS may interact with metallic objects, making treatment inadvisable in some cases.
- Patients with active, uncontrolled seizure disorders: Although the seizure risk with TMS is very low, patients with uncontrolled epilepsy or elevated seizure risk may require careful evaluation or be advised against the procedure.
- Those seeking treatment for conditions other than depression: TMS Revitalizes focuses its TMS services on treatment-resistant depression. Patients presenting primarily with other mental health conditions should discuss their full range of options with a qualified provider.
Eligibility determinations should always be made in collaboration with a clinician. Even patients who are uncertain about their candidacy may benefit from scheduling a consultation to gain clarity.
What to Expect During the Eligibility Evaluation Process
For patients in Missoula and across the broader western Montana region, the eligibility evaluation at TMS Revitalizes is designed to be thorough and patient-centered. The process generally involves several key components:
- Initial consultation: Patients meet with a clinician to discuss their depression history, current symptoms, and previous treatment experiences in detail.
- Medical record review: Documentation of past medication trials, therapy history, and any relevant medical conditions is assessed to establish a comprehensive clinical picture.
- Symptom assessment: Standardized depression rating scales, such as the PHQ-9, may be used to document symptom severity and create a baseline for tracking treatment progress over time.
- Treatment planning discussion: Patients learn about the logistics of TMS, including the typical schedule of five sessions per week over a course of four to six weeks, with each session lasting approximately 20 to 40 minutes.
This evaluation gives patients a clear understanding of whether TMS is clinically appropriate for them and what the treatment process will look like. For many, learning the practical details-including how much TMS therapy costs given their individual eligibility-helps reduce uncertainty and supports informed decision-making.
Why Eligibility Is About More Than Cost
While understanding how much does TMS therapy cost is an important and practical concern, eligibility considerations extend beyond financial factors. The clinical criteria for TMS exist to help ensure the treatment is directed toward patients who are most likely to benefit from it. As of 2026, the body of research supporting TMS for treatment-resistant depression continues to grow, reinforcing that its greatest efficacy is observed in patients with well-documented treatment resistance who have not found sufficient relief through standard pharmacological approaches.
The estimated 2,500 or more adults in Missoula County who may meet the criteria for treatment-resistant depression each year underscores the relevance of TMS as a local treatment option. Having access to a practice like TMS Revitalizes-one that is dedicated to evaluating and treating this specific patient population-can be a meaningful advantage for individuals navigating the complexities of treatment-resistant depression.
Take the Next Step Toward Understanding Your Options
If you have been living with depression that has not responded adequately to medications or therapy, a consultation is the best way to explore whether TMS may be right for you. The team at TMS Revitalizes in Missoula, MT, is ready to help you understand your eligibility, discuss what to expect from treatment, and address your questions about costs and coverage. Reach out to TMS Revitalizes today to schedule a consultation and take a proactive step toward exploring your treatment options.